It is interesting to note that oxymetholone does exhibit some tendency to convert to dihydrotestosterone in the body, although this does not occur via the 5-alpha reductase enzyme. Oxymetholone is already a dihydrotestosterone-based steroid, so no such alteration can take place. Aside from the added c-17 alpha alkylation (discussed below), oxymetholone differs from DHT only by the addition of a 2-hydroxymethylene group. This grouping can be removed metabolically, reducing oxymetholone to the potent androgen 17alpha-methyl dihydrotestosterone (mestanolone). 387 There is little doubt that this biotransformation contributes at least on some level to the androgenic nature of this steroid. Note that since 5-alpha reductase is not involved, the relative androgenicity of oxymetholone is not affected by the concurrent use of finasteride or dutasteride.
All manufacturers Aburaihan Alchemia Pharma Alpha Pharma Anhui Anke Biotechnology Arcas Nutrition Balkan Pharmaceuticals Bayer Bio-Peptide Biochem Bioniche Pharma Bioreaktor Biosira BM Pharmaceuticals Body Research British Dispensary British Dragon Canada Peptides Centurion Laboratories Cooper Desma Diamond Dynamic Labs Eifelfango Euro PharmLabs Excel Pharma Galenika GeneScience Genesis Hilma Biocare Iran Hormone Jelfa Jinan Pharmaceuticals Kohoh Pharma Kubera Pharma Lilly Magnus Pharmaceuticals Malay Tiger MultiPharm Nordex Norma Nouveaux Novo Nordisk Novosarm Onyx Organon Pfizer Pharmacom Phoenix Primus Ray Lab QPharma Royal Pharma Royal Pharmaceuticals Sandoz Sci Pharma Tech Shree Venkatesh SIS Labs SP Labarotories Spectrum Pharma Sport Pharma Swiss Remedies Titan Vermodje West Pharm Zenit Pharma ZPHC